FocalTherics (NASDAQ:FOCL) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.20) by 90 percent. This is a 123.53 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $13.200 million which missed the analyst consensus estimate of $14.440 million by 8.58 percent. This is a 28.38 percent decrease over sales of $18.431 million the same period last year.